<div id="Tab3" class="Table">
<div class="Caption" lang="en"><div class="CaptionContent">
<span class="CaptionNumber">Table 3</span> <p class="SimplePara">Treatment
 emergent adverse events (TEAEs) for all CZP-treated patients during the
 combined double-blind, dose-blind, and open-label periods of RAPID-PsA</p> </div></div>
<div class="u-scroll-horizontal"><table>
<colgroup>
<col class="tcol1 align-left">
<col class="tcol2 align-left">
<col class="tcol3 align-left">
</colgroup>
<thead>
<tr>
<th rowspan="2"> </th>
<th colspan="2"> <p class="SimplePara">All CZP dose combined (<em class="EmphasisTypeItalic ">N</em> = 393)</p> </th>
</tr>
<tr>
<th> <p class="SimplePara">DMARD+ (<em class="EmphasisTypeItalic ">n</em> = 279)</p> </th>
<th> <p class="SimplePara">DMARD− (<em class="EmphasisTypeItalic ">n</em> = 114)</p> </th>
</tr>
</thead>
<tbody>
<tr><td colspan="3"> <p class="SimplePara"><em class="EmphasisTypeItalic ">n</em> (%) [incidence rate; 95% CIs] Event rate per 100 patient exposure years</p> </td></tr>
<tr>
<td> <p class="SimplePara">Any TEAE</p> </td>
<td> <p class="SimplePara">260 (93.2)</p> <p class="SimplePara">[163.2; 143.9, 184.2]</p> <p class="SimplePara">257.4</p> </td>
<td> <p class="SimplePara">107 (93.9)</p> <p class="SimplePara">[160.2; 131.3, 193.6]</p> <p class="SimplePara">259.3</p> </td>
</tr>
<tr>
<td> <p class="SimplePara"> Mild</p> </td>
<td> <p class="SimplePara">239 (85.7)</p> <p class="SimplePara">[99.3; 87.1, 112.7]</p> <p class="SimplePara">160.3</p> </td>
<td> <p class="SimplePara">97 (85.1)</p> <p class="SimplePara">[99.9; 81.0, 121.8]</p> <p class="SimplePara">160.4</p> </td>
</tr>
<tr>
<td> <p class="SimplePara"> Moderate</p> </td>
<td> <p class="SimplePara">188 (67.4)</p> <p class="SimplePara">[44.8; 38.6, 51.7]</p> <p class="SimplePara">90.2</p> </td>
<td> <p class="SimplePara">73 (64.0)</p> <p class="SimplePara">[41.8; 32.8, 52.5]</p> <p class="SimplePara">89.0</p> </td>
</tr>
<tr>
<td> <p class="SimplePara"> Severe</p> </td>
<td> <p class="SimplePara">48 (17.2)</p> <p class="SimplePara">[5.4; 4.0, 7.2]</p> <p class="SimplePara">6.8</p> </td>
<td> <p class="SimplePara">23 (20.2)</p> <p class="SimplePara">[7.2; 4.6, 10.8]</p> <p class="SimplePara">9.9</p> </td>
</tr>
<tr>
<td> <p class="SimplePara">Discontinuations due to TEAEs</p> </td>
<td> <p class="SimplePara">34 (12.2)</p> <p class="SimplePara">[3.5; 2.4, 4.9]</p> <p class="SimplePara">4.1</p> </td>
<td> <p class="SimplePara">20 (17.5)</p> <p class="SimplePara">[5.7; 3.5, 8.8]</p> <p class="SimplePara">7.9</p> </td>
</tr>
<tr>
<td> <p class="SimplePara">Drug-related TEAEs</p> </td>
<td> <p class="SimplePara">135 (48.4)</p> <p class="SimplePara">[23.8; 20.0, 28.2]</p> <p class="SimplePara">56.6</p> </td>
<td> <p class="SimplePara">64 (56.1)</p> <p class="SimplePara">[31.5; 24.3, 40.3]</p> <p class="SimplePara">72.3</p> </td>
</tr>
<tr>
<td> <p class="SimplePara">Serious TEAEs</p> </td>
<td> <p class="SimplePara">73 (26.2)</p> <p class="SimplePara">[8.8; 6.9, 11.1]</p> <p class="SimplePara">11.5</p> </td>
<td> <p class="SimplePara">27 (23.7)</p> <p class="SimplePara">[8.5; 5.6, 12.4]</p> <p class="SimplePara">13.0</p> </td>
</tr>
<tr><td colspan="3"> <p class="SimplePara">Most frequent serious TEAEs and other TEAEs of interest</p> </td></tr>
<tr>
<td> <p class="SimplePara"> Infections and infestations<sup>a</sup></p> </td>
<td> <p class="SimplePara">16 (5.7)</p> <p class="SimplePara">[1.7; 1.0, 2.8]</p> <p class="SimplePara">2.0</p> </td>
<td> <p class="SimplePara">7 (6.1)</p> <p class="SimplePara">[2.0; 0.8, 4.2]</p> <p class="SimplePara">3.1</p> </td>
</tr>
<tr>
<td> <p class="SimplePara"> Musculoskeletal and connective tissue disorders<sup>a</sup></p> </td>
<td> <p class="SimplePara">14 (5.0)</p> <p class="SimplePara">[1.5; 0.8, 2.5]</p> <p class="SimplePara">2.0</p> </td>
<td> <p class="SimplePara">3 (2.6)</p> <p class="SimplePara">[0.9; 0.2, 2.5]</p> <p class="SimplePara">0.9</p> </td>
</tr>
<tr>
<td> <p class="SimplePara"> Gastrointestinal disorders<sup>a</sup></p> </td>
<td> <p class="SimplePara">2 (0.7)</p> <p class="SimplePara">[0.2; 0.0, 0.7]</p> <p class="SimplePara">0.2</p> </td>
<td> <p class="SimplePara">3 (2.6)</p> <p class="SimplePara">[0.9; 0.2, 2.5]</p> <p class="SimplePara">1.1</p> </td>
</tr>
<tr>
<td> <p class="SimplePara"> MACE<sup>b</sup></p> </td>
<td> <p class="SimplePara">6 (2.2)</p> <p class="SimplePara">[0.6; 0.2, 1.4]</p> <p class="SimplePara">0.6</p> </td>
<td> <p class="SimplePara">1 (0.9)</p> <p class="SimplePara">[0.3; 0.0, 1.6]</p> <p class="SimplePara">0.3</p> </td>
</tr>
<tr>
<td> <p class="SimplePara"> Malignancies<sup>c</sup></p> </td>
<td> <p class="SimplePara">5 (1.8)</p> <p class="SimplePara">[0.5; 0.2, 1.2]</p> <p class="SimplePara">0.5</p> </td>
<td> <p class="SimplePara">2 (1.8)</p> <p class="SimplePara">[0.6; 0.1, 2.1]</p> <p class="SimplePara">0.9</p> </td>
</tr>
<tr>
<td> <p class="SimplePara">Deaths</p> </td>
<td> <p class="SimplePara">5 (1.8)</p> <p class="SimplePara">[0.5; 0.2, 1.2]</p> <p class="SimplePara">0.5</p> </td>
<td> <p class="SimplePara">1 (0.9)</p> <p class="SimplePara">[0.3; 0.0, 1.6]</p> <p class="SimplePara">0.9</p> </td>
</tr>
</tbody>
</table></div>
<div class="TableFooter"> <p class="SimplePara">Safety
 Set. Incidence rates refer to the incidence of new cases per 100 
patient exposure years. Event rates are reported per 100 patient 
exposure years. TEAEs and serious TEAEs which occurred after the first 
CZP administration until 70 days after the last CZP administration 
were recorded</p> <p class="SimplePara"><em class="EmphasisTypeItalic ">CI</em> confidence intervals, <em class="EmphasisTypeItalic ">CZP</em> certolizumab pegol, <em class="EmphasisTypeItalic ">DMARD</em> disease-modifying anti-rheumatic drug, <em class="EmphasisTypeItalic ">MACE</em> major adverse cardiovascular events, <em class="EmphasisTypeItalic ">MedDRA</em> Medical Dictionary of Regulatory Activities, <em class="EmphasisTypeItalic ">TEAE</em> treatment emergent adverse event [<span class="CitationRef"><a href="#CR20" title="View reference" role="button" aria-expanded="false" aria-controls="popup-references">20</a></span>]</p> <p class="SimplePara"><sup>a</sup>Based on MedDRA system organ class</p> <p class="SimplePara"><sup>b</sup>MACE
 were identified using the search criteria for serious cardiovascular 
events: fatal and serious non-fatal myocardial infarction, 
cerebrovascular events, and congestive heart failure</p> <p class="SimplePara"><sup>c</sup>Malignancies were identified using the Standardized MedDRA Query (SMQ) “Malignancies”</p> </div>
</div>